awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36249922-6FFD95BB-BE49-4ADB-894B-899EE7CA6F3B
Q36249922-6FFD95BB-BE49-4ADB-894B-899EE7CA6F3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36249922-6FFD95BB-BE49-4ADB-894B-899EE7CA6F3B
The current and emerging role of immunotherapy in prostate cancer
P2860
Q36249922-6FFD95BB-BE49-4ADB-894B-899EE7CA6F3B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36249922-6FFD95BB-BE49-4ADB-894B-899EE7CA6F3B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
92abe582f6286b8ca412fcfdc8f07cacb5299489
P2860
Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial.